در حال جستجو در محتوی

ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده: 4 مورد
Anal squamous intraepithelial lesions: Epidemiology, clinical presentation, diagnosis, screening, prevention, and treatment
Anatomy, pathology, epidemiology, and risk factors of anal cancer
Clinical presentation, diagnosis, and staging of anal cancer
Treatment of anal cancer
Clinical characteristics of well-differentiated neuroendocrine tumors arising in the gastrointestinal and genitourinary tracts
Clinical features of carcinoid syndrome
Clinical presentation, imaging and biomarker monitoring, and prognosis of metastatic well-differentiated gastroenteropancreatic neuroendocrine tumors
Epithelial tumors of the appendix
Metastatic gastroenteropancreatic neuroendocrine tumors: Local options to control tumor growth and symptoms of hormone hypersecretion
Staging, treatment, and surveillance of localized well-differentiated gastrointestinal neuroendocrine tumors
Systemic therapy for metastatic well-differentiated low-grade (G1) and intermediate-grade (G2) gastrointestinal neuroendocrine tumors
Systemic therapy of metastatic well-differentiated pancreatic neuroendocrine tumors
Treatment of the carcinoid syndrome
Well-differentiated neuroendocrine tumors of the appendix
Adjunctive therapy for non-metastatic treated colorectal cancer: Aspirin, NSAIDs, and vitamin D
Adjuvant therapy after neoadjuvant therapy for rectal cancer
Adjuvant therapy for resected colon cancer in older adult patients
Adjuvant therapy for resected rectal adenocarcinoma not treated with neoadjuvant therapy
Adjuvant therapy for resected stage II colon cancer
Adjuvant therapy for resected stage III (node-positive) colon cancer
Approach to the care of colorectal cancer survivors
Clinical characteristics of well-differentiated neuroendocrine tumors arising in the gastrointestinal and genitourinary tracts
Clinical features of carcinoid syndrome
Clinical manifestations and diagnosis of familial adenomatous polyposis
Clinical presentation, diagnosis, and staging of colorectal cancer
Clinical presentation, imaging and biomarker monitoring, and prognosis of metastatic well-differentiated gastroenteropancreatic neuroendocrine tumors
Computed tomographic (CT) colonography in adults
Diagnosis of carcinoid syndrome and tumor localization
Epidemiology and risk factors for colorectal cancer
Familial adenomatous polyposis: Screening and management of patients and families
Fluoropyrimidine-associated cardiotoxicity: Incidence, clinical manifestations, mechanisms, and management
General principles of systemic therapy for metastatic colorectal cancer
Initial systemic therapy for metastatic colorectal cancer
Juvenile polyposis syndrome
Locoregional methods for management of metastatic colorectal cancer
Lynch syndrome (hereditary nonpolyposis colorectal cancer): Cancer screening and management
Lynch syndrome (hereditary nonpolyposis colorectal cancer): Clinical manifestations and diagnosis
MUTYH-associated polyposis
Management of metastatic colorectal cancer in older adults and those with a poor performance status
Metastatic gastroenteropancreatic neuroendocrine tumors: Local options to control tumor growth and symptoms of hormone hypersecretion
Molecular genetics of colorectal cancer
Neoadjuvant therapy for rectal adenocarcinoma
Nonsurgical local treatment strategies for colorectal cancer liver metastases
Overview of colon polyps
Overview of the management of primary colon cancer
Overview of the management of rectal adenocarcinoma
Pathology and prognostic determinants of colorectal cancer
Peutz-Jeghers syndrome: Clinical manifestations, diagnosis, and management
Post-treatment surveillance for colorectal cancer
Potentially resectable colorectal cancer liver metastases: Integration of surgery and chemotherapy
Pretreatment locoregional staging evaluation for rectal cancer
Screening for colorectal cancer in patients with a family history of colorectal cancer or advanced polyp
Screening for colorectal cancer: Strategies in patients at average risk
Second- and later-line systemic therapy for metastatic colorectal cancer
Staging, treatment, and surveillance of localized well-differentiated gastrointestinal neuroendocrine tumors
Surgical treatment of rectal cancer
Surveillance and management of dysplasia in patients with inflammatory bowel disease
Systemic therapy for metastatic well-differentiated low-grade (G1) and intermediate-grade (G2) gastrointestinal neuroendocrine tumors
Systemic therapy of metastatic well-differentiated pancreatic neuroendocrine tumors
Treatment of locally recurrent rectal adenocarcinoma
Treatment of the carcinoid syndrome
Adjuvant and neoadjuvant therapy for gastrointestinal stromal tumors
Barrett's esophagus: Pathogenesis and malignant transformation
Clinical manifestations, diagnosis, and staging of esophageal cancer
Clinical presentation, diagnosis, and prognosis of gastrointestinal stromal tumors
Endoscopic ultrasound for the characterization of subepithelial lesions of the upper gastrointestinal tract
Epidemiology and risk factors for esophageal cancer
Initial systemic therapy for metastatic esophageal and gastric cancer
Local treatment for gastrointestinal stromal tumors, leiomyomas, and leiomyosarcomas of the gastrointestinal tract
Management of locally advanced unresectable or inoperable esophageal cancer
Management of superficial esophageal cancer
Neoadjuvant and adjuvant therapy for locally advanced resectable esophagogastric junction and gastric cardia adenocarcinoma
Neoadjuvant and adjuvant therapy for locally advanced resectable thoracic esophageal cancer
Second- and later-line systemic therapy for metastatic gastric and esophageal cancer
Surgical management of resectable esophageal and esophagogastric junction cancers
Adjuvant and neoadjuvant therapy for localized resectable cholangiocarcinoma
Adjuvant therapy for localized resected gallbladder cancer
Ampullary carcinoma: Treatment and prognosis
Assessment of tumor response in patients receiving systemic and nonsurgical locoregional treatment of hepatocellular cancer
Clinical features and diagnosis of hepatocellular carcinoma
Clinical manifestations and diagnosis of cholangiocarcinoma
Epidemiology and risk factors for hepatocellular carcinoma
Epidemiology, clinical manifestations, diagnosis, and treatment of fibrolamellar carcinoma
Epidemiology, clinical presentation, diagnosis, and staging of ampullary carcinoma
Epidemiology, risk factors, anatomy, and pathology of cholangiocarcinoma
Epidemiology, risk factors, clinical features, and diagnosis of gallbladder cancer
Hepatotoxicity of molecularly targeted agents for cancer therapy
Liver transplantation for hepatocellular carcinoma
Localized hepatocellular carcinoma: Liver-directed therapies for nonsurgical candidates eligible for local ablation
Localized hepatocellular carcinoma: Liver-directed therapies for nonsurgical candidates not eligible for local thermal ablation
Management of potentially resectable hepatocellular carcinoma: Role of neoadjuvant and adjuvant therapy, and posttreatment surveillance
Overview of hepatoblastoma
Overview of treatment approaches for hepatocellular carcinoma
Pathology of malignant liver tumors
Preoperative portal vein embolization
Staging and prognostic factors in hepatocellular carcinoma
Surgical resection of hepatocellular carcinoma
Systemic therapy for advanced unresectable and metastatic cholangiocarcinoma
Systemic therapy for advanced unresectable and metastatic gallbladder cancer
Systemic treatment for advanced unresectable and metastatic hepatocellular carcinoma
Treatment of locally advanced unresectable nonmetastatic cholangiocarcinoma
Gastric intestinal metaplasia
Malignancy-related ascites
Malignant peritoneal mesothelioma: Epidemiology, risk factors, clinical presentation, diagnosis, and staging
PTEN hamartoma tumor syndromes, including Cowden syndrome
Peritoneal mesothelioma: Treatment
Classification, clinical presentation, diagnosis, and staging of pancreatic neuroendocrine neoplasms
Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer
Clinical presentation, diagnosis, and management of VIPoma
Clinical presentation, imaging and biomarker monitoring, and prognosis of metastatic well-differentiated gastroenteropancreatic neuroendocrine tumors
Endoscopic ultrasound in the staging of exocrine pancreatic cancer
Epidemiology and nonfamilial risk factors for exocrine pancreatic cancer
Familial risk factors for pancreatic cancer and screening of high-risk patients
Glucagonoma and the glucagonoma syndrome
Initial management of locally advanced unresectable or borderline resectable exocrine pancreatic cancer
Initial systemic therapy for metastatic exocrine pancreatic cancer
Insulinoma
Management and prognosis of gastrinoma (Zollinger-Ellison syndrome)
Metastatic gastroenteropancreatic neuroendocrine tumors: Local options to control tumor growth and symptoms of hormone hypersecretion
Molecular pathogenesis of exocrine pancreatic cancer
Overview of surgery in the treatment of exocrine pancreatic cancer and prognosis
Overview of tumor biomarkers in gastroenteropancreatic neuroendocrine tumors
Pathology and classification of gastroenteropancreatic neuroendocrine neoplasms
Pathology of exocrine pancreatic neoplasms
Poorly differentiated gastroenteropancreatic neuroendocrine carcinoma
Second- and later-line systemic therapy for metastatic exocrine pancreatic cancer
Somatostatinoma: Clinical manifestations, diagnosis, and management
Supportive care for locally advanced or metastatic exocrine pancreatic cancer
Surgical resection of sporadic pancreatic neuroendocrine neoplasms
Systemic therapy for metastatic well-differentiated low-grade (G1) and intermediate-grade (G2) gastrointestinal neuroendocrine tumors
Systemic therapy of metastatic well-differentiated pancreatic neuroendocrine tumors
Total pancreatectomy
Treatment for potentially resectable exocrine pancreatic cancer
Well-differentiated high-grade (G3) gastroenteropancreatic neuroendocrine tumors
Zollinger-Ellison syndrome (gastrinoma): Clinical manifestations and diagnosis
Adjuvant and neoadjuvant therapy for gastrointestinal stromal tumors
Clinical characteristics of well-differentiated neuroendocrine tumors arising in the gastrointestinal and genitourinary tracts
Clinical presentation and diagnosis of primary gastrointestinal lymphomas
Clinical presentation, diagnosis, and prognosis of gastrointestinal stromal tumors
Clinical presentation, imaging and biomarker monitoring, and prognosis of metastatic well-differentiated gastroenteropancreatic neuroendocrine tumors
Diagnosis and staging of small bowel neoplasms
Diagnosis of carcinoid syndrome and tumor localization
Endoscopic ultrasound for the characterization of subepithelial lesions of the upper gastrointestinal tract
Epidemiology and clinical features of small bowel neoplasms
Local treatment for gastrointestinal stromal tumors, leiomyomas, and leiomyosarcomas of the gastrointestinal tract
Metastatic gastroenteropancreatic neuroendocrine tumors: Local options to control tumor growth and symptoms of hormone hypersecretion
Staging, treatment, and surveillance of localized well-differentiated gastrointestinal neuroendocrine tumors
Systemic therapy for metastatic well-differentiated low-grade (G1) and intermediate-grade (G2) gastrointestinal neuroendocrine tumors
Systemic therapy of metastatic well-differentiated pancreatic neuroendocrine tumors
Treatment of small bowel neoplasms
Treatment of the carcinoid syndrome
Adjuvant and neoadjuvant therapy for gastrointestinal stromal tumors
Adjuvant and neoadjuvant treatment of gastric cancer
Clinical characteristics of well-differentiated neuroendocrine tumors arising in the gastrointestinal and genitourinary tracts
Clinical presentation and diagnosis of primary gastrointestinal lymphomas
Clinical presentation, diagnosis, and prognosis of gastrointestinal stromal tumors
Clinical presentation, diagnosis, and staging of gastric cancer
Clinical presentation, imaging and biomarker monitoring, and prognosis of metastatic well-differentiated gastroenteropancreatic neuroendocrine tumors
Diagnosis of carcinoid syndrome and tumor localization
Diffuse gastric and lobular breast cancer syndrome
Early gastric cancer: Clinical features, diagnosis, and staging
Early gastric cancer: Management and prognosis
Endoscopic ultrasound for the characterization of subepithelial lesions of the upper gastrointestinal tract
Gastric cancer screening
Gastric cancer: Pathology and molecular pathogenesis
Gastric polyps
Local palliation for advanced gastric cancer
Local treatment for gastrointestinal stromal tumors, leiomyomas, and leiomyosarcomas of the gastrointestinal tract
Metastatic gastroenteropancreatic neuroendocrine tumors: Local options to control tumor growth and symptoms of hormone hypersecretion
Postgastrectomy complications
Risk factors for gastric cancer
Staging, treatment, and surveillance of localized well-differentiated gastrointestinal neuroendocrine tumors
Surgical management of invasive gastric cancer
Systemic therapy for metastatic well-differentiated low-grade (G1) and intermediate-grade (G2) gastrointestinal neuroendocrine tumors
Systemic therapy of metastatic well-differentiated pancreatic neuroendocrine tumors
Treatment of the carcinoid syndrome